Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-19
DOI
10.1038/srep39209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjunctive Brexpiprazole: A Review in Major Depressive Disorder
- (2016) Kate McKeage CNS DRUGS
- Mechanism of action of brexpiprazole: comparison with aripiprazole
- (2016) Stephen M. Stahl CNS SPECTRUMS
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- (2016) Ji-chun Zhang et al. Current Neuropharmacology
- Regional differences in the expression of brain-derived neurotrophic factor (BDNF) pro-peptide, proBDNF and preproBDNF in the brain confer stress resilience
- (2016) Bangkun Yang et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress
- (2016) Qian Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression
- (2016) Bangkun Yang et al. PSYCHOPHARMACOLOGY
- Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model
- (2016) H-L Sun et al. Translational Psychiatry
- Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study
- (2015) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
- (2015) Christoph U. Correll et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders
- (2015) Y. Ohgi et al. CURRENT MOLECULAR MEDICINE
- Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin–dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors
- (2015) Tamaki Ishima et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat
- (2015) Carl Björkholm et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist
- (2015) Yukihiko Shirayama et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin–dopamine activity modulator
- (2015) Noriko Yoshimi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- Regional Differences in Brain-Derived Neurotrophic Factor Levels and Dendritic Spine Density Confer Resilience to Inescapable Stress
- (2015) C. Yang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
- (2015) Ji-chun Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder
- (2015) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHIATRY
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression
- (2015) Ji-chun Zhang et al. PSYCHOPHARMACOLOGY
- Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression
- (2015) Wen-Xue Liu et al. PSYCHOPHARMACOLOGY
- A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
- (2015) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
- (2015) Leslie Citrome et al. Expert Review of Neurotherapeutics
- BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms
- (2015) Q Ren et al. Translational Psychiatry
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- BDNF Release Is Required for the Behavioral Actions of Ketamine
- (2015) A. E. Lepack et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
- (2014) Elizabeth Brunner et al. NEUROPSYCHOPHARMACOLOGY
- Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors
- (2014) Noriko Yoshimi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rational site-directed pharmacotherapy for major depressive disorder
- (2013) Pierre Blier INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine
- (2013) Qian Ren et al. PSYCHOPHARMACOLOGY
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice
- (2011) Maxime Cazorla et al. JOURNAL OF CLINICAL INVESTIGATION
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- A standardized protocol for repeated social defeat stress in mice
- (2011) Sam A Golden et al. Nature Protocols
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
- (2010) S.-W. Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder
- (2008) Richard C. Shelton et al. ACTA PSYCHIATRICA SCANDINAVICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now